GL1X · GenesisL1 explorer

Research workbench

Human aldose reductase in complex with NADP and citrate at 0.82 ångström

Analyse Human aldose reductase in complex with NADP and citrate at 0.82 ångström in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2J8T
Type
protein
Length
316 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Aldo-keto reductase family 1, member B1
EC
1.1.1.21
UniProt
Q5U031
Ligands
NAP
Pockets
1 · best druggability 0.69

Structure

x-ray diffraction · 1 distinct chain · 39% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAldo-keto reductase family 1, member B1 (EC 1.1.1.21)protein31639% helix, 15% strandQ5U031

Ligands and binding sites

  • NAP · Nadp nicotinamide-adenine-dinucleotide phosphate · ligand · chains A
  • FLC · Citrate anion · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13350.690.8248NAP, FLC

Compared structures

  • 2J8T · Human aldose reductase in complex with NADP and citrate at 0.82 angstrom · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.